Dotarizine
Dotarizine is a vasodilator and calcium channel blocker that was developed for the treatment of migraine. It is a member of the diphenylmethylpiperazine group of compounds and was developed in the 1980s by the Spanish pharmaceutical company Esteve.
Pharmacology[edit]
Dotarizine acts as a calcium channel blocker, specifically blocking L-type and T-type calcium channels. This action is believed to contribute to its efficacy in treating migraine. In addition to its calcium channel blocking activity, dotarizine also acts as a vasodilator, increasing blood flow in the brain. This is thought to further contribute to its anti-migraine effects.
Clinical Use[edit]
Dotarizine has been studied for the treatment of migraine and vertigo. Clinical trials have shown it to be effective in reducing the frequency and severity of migraine attacks. It has also been found to be beneficial in the treatment of vertigo associated with Meniere's disease and other vestibular disorders.
Side Effects[edit]
The most common side effects of dotarizine are drowsiness and weight gain. Other side effects can include dry mouth, constipation, and blurred vision. As with all medications, the potential benefits of treatment with dotarizine should be weighed against the potential risks.
Availability[edit]
Dotarizine is not currently available in the United States, but it is available in some European countries.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
